Projects per year
Personal profile
Research interests
Dr. Monika Joshi’s research focus is in the field of genitourinary tumors, particularly in the field of immunotherapy and targeted therapy.
Clinical interests
Dr. Monika Joshi developed clinical and translational expertise in genitourinary malignancies. This experience has positioned her to undertake several innovative clinical trials with multiple collaborations and national participation. She is the disease team co-leader for the genitourinary diseases group at Penn State Cancer Institute. In addition she holds regional and national leadership roles as the co-chair for the genitourinary committee for the Big Ten Cancer Research Consortium and is also as a representative for the Pennsylvania Governor's Advisory Panel on Genetics and Genomics.
Dr. Joshi has a keen interest in developing clinical trials with novel immunotherapeutic combinations and identifying predictive and prognostic biomarkers.
Professional information
Certification, Educational Commission for Foreign Medical Graduates (ECFMG), 2006
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Fellowship, Penn State Health Milton S. Hershey Medical Center
… → 2013
Residency, UPMC Pinnacle
… → 2010
Specialist Registrar (Fellow), University Hospitals Coventry and Warwickshire NHS Trust
… → 2007
MBBS, Manipal Academy of Higher Education
… → 2001
Fingerprint
Dive into the research topics where Monika Joshi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Early clinial trials for Angelica herbal supplements for prostate cancer interception
Lu, J. J. & Joshi, M.
9/1/22 → 8/31/24
Project: Research project
-
Alzheimer's disease and related dementias is a risk factor for lower utilization of breast cancer screening and unstaged cancer diagnosis: Observational study from SEER-Medicare 2004–2016 data
Weng, X., Shen, C., Vasekar, M., Boltz, M., Joshi, M., Van Scoy, L. J. & Wang, L., Apr 2023, In: Journal of Geriatric Oncology. 14, 3, 101407.Research output: Contribution to journal › Article › peer-review
-
Behaviors and Advocacy Related to COVID-19 among Cancer Patients: The Health Belief Model and Opportunities for Messaging and Education
Ledford, S. G., Moss, J. L., Alles, S., Wang, M., Kessler, F. C., Marks, B., Soliman, A. S., Joshi, M. D. & Lengerich, E. J., Oct 2023, In: Journal of Cancer Education. 38, 5, p. 1690-1696 7 p.Research output: Contribution to journal › Article › peer-review
-
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
Choueiri, T. K., Labaki, C., Bakouny, Z., Hsu, C. Y., Schmidt, A. L., de Lima Lopes, G., Hwang, C., Singh, S. R. K., Jani, C., Weissmann, L. B., Griffiths, E. A., Halabi, S., Wu, U., Berg, S., O'Connor, T. E., Wise-Draper, T. M., Panagiotou, O. A., Klein, E. J., Joshi, M., Yared, F., & 24 others, Mar 2023, In: The Lancet Regional Health - Americas. 19, 100445.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: Results from phase II study, BTCRC-GU15-023
Joshi, M., Tuanquin, L., Zhu, J., Walter, V., Schell, T., Kaag, M., Kilari, D., Liao, J., Holder, S. L., Emamekhoo, H., Sankin, A., Merrill, S., Zheng, H., Warrick, J., Hauke, R., Gartrel, B., Stein, M., Drabick, J., Degraff, D. J. & Zakharia, Y., Feb 23 2023, In: Journal for ImmunoTherapy of Cancer. 11, 2, e006551.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources Uniformly
on behalf of the Global Society of Rare Genitourinary Tumors (GSRGT) and the International Bladder Cancer Group (IBCG), Apr 2023, In: Clinical Genitourinary Cancer. 21, 2, p. 301-308 8 p.Research output: Contribution to journal › Comment/debate › peer-review